Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 30, 2014, 02:29:20 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 632396
  • Total Topics: 47892
  • Online Today: 294
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Herpes treatment may control AIDS virus  (Read 1671 times)

0 Members and 1 Guest are viewing this topic.

Offline pozgroup

  • Member
  • Posts: 17
    • PozGroup.com
Herpes treatment may control AIDS virus
« on: March 16, 2007, 04:57:22 AM »
Treating genital herpes can help keep the AIDS virus under control in women with both infections, and may help reduce the spread of HIV.
Many people with HIV are also infected with the herpes type 2 virus, and scientists have long known that herpes sores on the genitals can make it easier to become infected with the AIDS virus and could increase the risk of transmitting HIV to others.
In the latest study on the diseases, conducted in Africa and published in yesterday's New England Journal of Medicine, women who took the herpes drug valacyclovir had less HIV in their blood and in their genital secretions.

The study did not look at whether the drug, sold as Valtrex by GlaxoSmithKline, actually reduced transmission of the AIDS virus. However, scientists generally have found that the more virus someone has, the greater the risk of transmission.

Doctors have been looking for novel ways to treat and prevent HIV infection, particularly in poor countries where few can afford modern AIDS drugs and the stigma keeps many from taking them.

Researchers recently found that circumcision lowers the risk of spreading HIV, and they hope the same will prove true of treating herpes.

"It does open some potential avenues to slowing down the HIV epidemic," said Lawrence Corey, a leading herpes researcher at the University of Washington who had no role in the study but has received research grants from Glaxo.

There are 40,000 new HIV infections in the US each year and 4.3 million new cases worldwide. Previous studies have shown that herpes infections can triple a person's chance of acquiring HIV and can make HIV-positive individuals more infectious.

In the study, 140 women from the West African nation of Burkina Faso who were infected with both the herpes and AIDS viruses received either valacyclovir or dummy pills for three months. Participants were not taking other AIDS medications.

Doctors took vaginal swabs and drew blood samples twice a week to measure HIV levels.

Those who took the drug ended up with less HIV in the bloodstream, with their count dropping from an average 20,000 virus copies per millilitre of blood to 8000 copies. The placebo group saw their HIV levels spike, from an average of 50,000 virus copies/ml of blood to 63,000.

The treatment group was also less likely to have HIV in their genital tracts - 13 per cent had detectable virus levels during each visit, compared with 27 per cent in the placebo group.

The study involved researchers from France, England and Burkina Faso and was funded by the French national AIDS research agency, ANRS.

A larger study funded by the Bill and Melinda Gates Foundation is under way.

It aims to be the definitive word on whether treating herpes patients with acyclovir, the first herpes drug, can slow down HIV transmission.
http://www.pozgroup.com--Living with STD, but not lonely!

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.